Velsera was formed in 2023 through the shared vision of Seven Bridges and Pierian, with a mission to accelerate the discovery, development, and delivery of life-changing insights.
Velsera provides software and professional services for:
• Multimodal Data Harmonization & Analytics for Drug Discovery & Development
• IVD Development, Validation & Approval
• Clinical NGS Interpretation, Reporting & Adoption
Join our community (support.velsera.com/hc/en-us/community/topics) and explore our solutions (velsersa.com/solutions).
Let's drive the future of precision medicine - together.
Company Details
- Employees
- 552
- Founded
- 2023
- Address
- Schrafft’s City Center 529 Main St, Suite 6610, Charlestown,ma 02129,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://velsera.com
- Keywords
- for:.
- HQ
- Charlestown, MA
Velsera Questions
Velsera's website is http://velsera.com
Velsera's LinkedIn profile is https://www.linkedin.com/company/velseraofficial
Velsera has
552 employees.
View email and phone details for 552
employees at Velsera.
Velsera's industry is
Biotechnology Research
Velsera's top competitors are
Elucidata,
Illumina,
Dnanexus,
4basecare,
Seven Bridges,
Strand Life Sciences,
Excelra,
Pierian,
Ugentec,
Medgenome.
Velsera's categories are Biotechnology Research
Velsera's founding year is 2023
